Technology | 2017.05.22
BioVentrix announces the 1st Revivent TC™ TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment at Deutsches Herzzentrum Berlin in Germany
SAN RAMON, Calif., and BERLIN, May 22, 2017 /PRNewswire/ -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the first clinical use of its closed-chest Revivent TC™ TransCatheter Ventricular Enhancement System at...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]rlin-in-germany-300460446.html
